US88167AAE10 · Corp · USD

Teva Pharmaceutical Finance Nether 3.15% 2026/10

MID PRICE
99.30
par = 100
YIELD TO MAT.
4.85%
semi-annual
COUPON
3.150%
semi-annual · fixed
MATURITY
2026-10-01
bullet · 0.41y
OUTSTANDING
not disclosed
AS OF
2026-04-30
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
0.40 y
1bp ↑ ≈ -0.004% P&L
Convexity
0.36
higher = more curvature
Years to maturity
0.41 y
YTM source
Ingested
Fund disclosure
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares 0-5 Year High Yield Corporate Bond
iShares
US HY Corporate 0-5Y$11.1M▲ $10K0.15%2026-04-30
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-30

Institutional footprint · signal-level holdings

17/ 100Minimal footprint
Interpretation. Minimal institutional footprint, holding
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$11.1M
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
▲ $15K
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
99,300 USD
PRICE
99.30

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
TEVA 3.15 10/01/26
FIGI
BBG00DDM0BW8
CUSIP
88167AAE1
ISIN
US88167AAE10
Type
Corp
Issued
2016-07-21
Face value
100 USD
Ticker
TEVA 3.15 10/01/26
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

TEVA · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.